Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 10:33 PM

Antigen

Type: Keyphrase
Name: Antigen
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Health)
Rapid H1N1 Tests Miss the Virus in Most ICU Patients
The sensitivity of a rapid antigen test for pandemic H1N1 influenza was poor in Australian intensive care patients, researchers found in a small study.In 20 infected patients who had acute lung injury requiring mechanical ventilation, the QuickVue A+B ... [MedPage Today - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
Novartis AG - Click to view image in its original context
Novartis AG
Novartis discloses clinical data of H1N1 vaccine
BASEL, Switzerland (Nov. 18) Novartis on Tuesday announced new interim data from ongoing clinical trials demonstrating that a single 7.5-µg dose of the company's influenza A(H1N1) 2009 unadjuvanted vaccine, half of the currently approved U.S. dose, fulfilled ... [Drug Store News - 11/19/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents (in Health)
Did U.S. make a swine flu mistake? (Reuters)
WASHINGTON (Reuters) As U.S. health officials struggle to vaccinate tens of millions of Americans against the pandemic of swine flu, some are looking regretfully at one easy way to instantly double or triple the number of doses available -- by using an ... [Yahoo! News - 11/20/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
A single step process for the synthesis of antigen laden thermosensitive microparticles
Bruno G. De Geest, Stefaan De Koker, Yves Gonnissen, Liesbeth J. De Cock, Johan Grooten, Jean Paul Remon and Chris VervaetRecent insights in vaccine delivery point out a distinct benefit for antigen to be delivered in a microparticulate form to professional ... [RSC - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Health)
Donated blood may be unsafe even after test
NEW DELHI: Donated blood being transfused into you may not be entirely safe, even after it has undergone the present day gold standard Elisa test. This has now been confirmed by an AIIMS study.After studying 5,818 donated blood samples that tested safe ... [Times of India - 11/19/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results
Expert Review of Vaccines, 10/06/09 Relevance Score: 68%Immunology, 11/11/09 Relevance Score: 67%Annals of Internal Medicine, 10/21/09 Relevance Score: 67%The Lancet, 10/19/09 Relevance Score: 67%GlaxoSmithKline, 10/19/09 Relevance Score: 67% ... [MDLinx - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents (in Health)
TapImmune, Inc. (TPIV.OB) is âOne to Watchâ
TapImmune, Inc. is a biotechnology company focused on developing innovative therapeutics and vaccines in the areas of oncology and infectious disease. The company’s lead product, the TAP vaccine, moves characteristic markers called antigens to the surfaces ... [International Business Times - 11/20/2009]
First Reported 17 hours ago - Updated 17 hours ago - 1 Documents
Novartis: US interim data show lower doses of antigen may suffice to generate a protective immune response against A(H1N1)
ovartis announced new interim data from ongoing clinical trials demonstrating that a single 7.5 ... [Bionity.com - 17 hours ago]
First Reported 11/18/2009 - Updated 11/18/2009 - 2 Documents (in Health)
Novartis’ Swine Flu Vaccine Effective at Half the Current Antigen Dose
Swine Flu Vaccine Effective at Half the Current Antigen Dose. if 0) 0) if 0) 0) if 0) 0) Infectious Diseases More Nov 17 2009, 10:19 AM EST ’ Swine Flu Vaccine ... [Genetic Engineering News - 11/18/2009]
First Reported 11/16/2009 - Updated 11/16/2009 - 3 Documents (in Health)
Human Genome Sciences Receives Complete Response Letter from FDA for Raxibacumab Biologics...
BusinessWire - Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) relating to the Company's Biologics License Application (BLA) requesting the approval ... [Forbes.com - 11/16/2009]
First Reported 11/16/2009 - Updated 11/16/2009 - 2 Documents (in Health)
H1N1 watch: Monday (Impolitical)
The decision to go with an adjuvanted vaccine is a choice that keeps causing problems: "Hundreds of flu vaccine doses thrown out."Most flu vaccines can last up to a month after being injected, but Arepanrix, the H1N1 vaccine, is more difficult to manage. ... [Progressive Bloggers - 11/16/2009]
First Reported 11/16/2009 - Updated 11/17/2009 - 2 Documents (in Health)
Nov 13 Novartis press release
Swissmedic approval allows Novartis to begin shipments of Celtura to Switzerland, providing supplies of A(H1N1) vaccine immediatelyApprovals in Germany and Switzerland demonstrate expanded adoption of new cell culture technology -- an important milestone ... [Centre For Infectious Disease Research and Policy - 11/17/2009]

Quotes

...But unlike Elisa which would cost around Rs 100, NAT costs 10 times more. "NAT amplifies the genetic material of the viruses multifold in a very short period of analysis time. This amplifies even very low amounts of genetic material that cannot be identified by normal testing methods in the window period" Dr Chatterjee said
Donated blood may be unsafe even after test [Times of India - 11/19/2009]
Dr. J Joseph Kim, Inovios President and CEO, said, "Chikungunya virus represents a clear unmet need because it is endemic in many regions of the world and has epidemic potential. With our recent clinical trial data showing our vaccine platforms ability to induce strong antibody responses in vaccinated subjects, we hope to be able to translate these preclinical successes presented in the current study into clinical progress in the near future. Inovios novel SynCon" technology enables the company to design DNA-based vaccines with the potential to protect against known and unknown strains of pathogens...
Inovio Biomedical Universal DNA Vaccine for Chikungunya Virus Demonstrates Protective Antibody Re ... [Business Wire - 11/18/2009]
...vaccines supply, protecting more people earlier against the current pandemic,' said Andrin Oswald, CEO of Novartis Vaccines and Diagnostics. "The data also confirms the antigen sparing potential of our proprietary adjuvant, MF59®. The vaccines output of our Liverpool, U K , based flu manufacturing facility, fully dedicated to the US since the emergence of the pandemic, could be quadrupled if vaccines are adjuvanted." These interim data were generated from pivotal clinical studies designed to evaluate the immunogenicity, safety and reactogenicity of both MF59-adjuvanted...
Lower doses of antigen may suffice to generate a protective immune response against A(H1N1) [World Pharma News - 11/18/2009]

More Content

All (1258) | News (1043) | Reports (25) | Blogs (47) | Audio/Video (2) | Fact Sheets (0)
sort by: Date | Relevance
Potential Peak In US Swine Flu Cases [Red Orbit - 7 hours ago]
Novartis: US interim data show lower doses of a... [Bionity.com - 17 hours ago]
Identifying virally infected and vaccinated org... [PharmCast - 20 hours ago]
Dendreon Corporation (DNDN) (JOBS) Receives FDA... [BioSpace - 21 hours ago]
Antigenics Inc. (New York) (AGEN) Cancer Vaccin... [BioSpace - 21 hours ago]
Revised Cancer Screening Recommendations [Suite101.com - 11/20/2009]
Skin grafts from stem cells [NHS Choices - 11/20/2009]
Panel: FluBlok Safety, Efficacy Data Insufficie... [BioWorld - 11/20/2009]
TapImmune, Inc. (TPIV.OB) is âOne to Watch... [International Business Times - 11/20/2009]
Scientists identify DNA that regulates antibody... [PhysOrg.com - 11/20/2009]
Did U.S. make a swine flu mistake? (Reuters) [Yahoo! News - 11/20/2009]
Stocks to Watch: IMUC [Pharmacy Choice - 11/20/2009]
Dendreon Receives FDA Acknowledgement of Comple... [FinanzNachrichten.de - 11/20/2009]
Phase I Clinical Trial of an Adenovirus/Prostat... [MDLinx - 11/20/2009]
Medicago announces filing of final short form p... [Canoe Money - 11/20/2009]
Speakers confront HIV apathy [Mc Gill Daily - 11/20/2009]
Researchers to discover new vaccine against inf... [News-Medical.Net - 11/20/2009]
Medicago announces filing of final short form p... [Globe Investor - 11/20/2009]
Medicago announces filing of final short form p... [Canadian Business Magazine - 11/20/2009]
Patient Decision Aids for Prostate Cancer Treat... [CA: A Cancer Journal for Clinicians - 11/19/2009]
Inovio Biomedical Corporation (INO) Universal D... [BioSpace - 11/19/2009]
Prostate specific antigen levels reduced by sta... [MedWire News - 11/19/2009]
TURP useful for excluding prostate cancer after... [MedWire News - 11/19/2009]
AS feasible for favorable-risk prostate cancer ... [MedWire News - 11/19/2009]
Donated blood may be unsafe even after test [Times of India - 11/19/2009]
Dynavax Technologies Corporation (DVAX) Complet... [BioSpace - 11/19/2009]
A single step process for the synthesis of anti... [RSC - 11/19/2009]
ImmunoCellular Therapeutics Issues Letter to Sh... [Business Wire - 11/19/2009]
DPRK develops reagent for diagnosis of hepatiti... [People's Daily Online - 11/19/2009]
Dynavax Completes Enrollment of First Cohort of... [Market Wire via MSN Money - 11/19/2009]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
David Butler-Jones, Andrin Oswald, PHASE 2, [more]
  •  
Novartis AG, Advaxis, CSL Ltd, [more]
  •  
Food and Drug Administration, US Department of Health, World Health Organization, [more]
  •  
Vaccine, Prostate Cancer, Antibody, [more]
  •  
Toronto, Quebec, Marburg (Germany), [more]
  •  
United States, Canada, Mexico, [more]
  •  
Medicine, Biology, Medication, [more]
  •  
Pharma & Biotech, Health, IT, [more]
PharmCast, PharmaBiz, MDLinx, [more]
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
Did U.S. make mistake in skipping vaccine addit... [Economy-Finance - 11/20/2009]
By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - As U.S. health officials struggle to vaccinate tens of millions of Americans against the pandemic ...
New and Exciting in PLoS this week [A Blog Arou... [ScienceBlogs : Combined Feed - 11/20/2009]
Friday - PLoS Genetics, Pathogens, Computational Biology and ONE published today. As always, you should rate the articles, post notes and comments and send trackbacks ...
Is The H1N1 Flu Vaccine Going To Give Me Gulf W... [Treehugger - 11/16/2009]
No, this isn't another article about mercury in vaccines, it is also not about vaccines causing autism, nor is it about . This article is about an entirely different ...
H1N1 watch: Monday (Impolitical) [Progressive Bloggers - 11/16/2009]
The decision to go with an adjuvanted vaccine is a choice that keeps causing problems: "Hundreds of flu vaccine doses thrown out."Most flu vaccines can last up to ...
Canada's flu vaccine leftovers being sent overseas [H5N1 - 11/04/2009]
Via the Globe and Mail: Canada's flu vaccine leftovers being sent overseas. Excerpt:Bulk shipments of the main component of the H1N1 vaccine made at a Quebec plant ...
1 2 3 4 5 6 7 8 9 10

Audio/Video

sort by: Date | Relevance
Mayo Clinic Study Suggests Routine Prostate Siz... [Mayo Clinic - YouTube - 11/09/2009]
MTS29 - Christine Biron - The Innate Immune System [Mefeedia Video Tag : nanotechnology - 06/18/2009]
1

  •  
  •  
  •